Isosibiricin inhibits microglial activation by targeting the dopamine D1/D2 receptor-dependent NLRP3/caspase-1 inflammasome pathwayYan-Hang Wang, Ke‐Wu Zeng|Acta Pharmacologica Sinica|2019Cited by 31